Cochrane Summaries

Trusted evidence. Informed decisions. Better health.
Language:
English

Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia

Barnes TRE, Soares-Weiser K, Bacaltchuk J
Published Online: 
12 May 2010

Akathisia is recognised as one of the most common and distressing of the early-onset adverse effects of neuroleptic drugs. This movement disorder is characterised by a subjective report of inner restlessness, mental unease or dysphoria, which can be intense.

This review highlights the limited evidence available to support the use of central action beta-blockers for neuroleptic-induced acute akathisia.

This record should be cited as: 
Barnes TRE, Soares-Weiser K, Bacaltchuk J. Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD001946. DOI: 10.1002/14651858.CD001946.pub2
Assessed as up to date: 
4 August 2004